BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: A$0.18 M
• Last 3 months FTD volume: A$0.39 M
• Last year FTD volume: A$0.39 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$3.47 M	A$65.4 M	🇺🇸 USA
Sarepta Therapeutics SRPT	A$0.94 M	A$34.64 M	🇺🇸 USA
NanoViricides NNVC	A$1.02 M	A$2.93 M	🇺🇸 USA
Novavax NVAX	A$12.75 M	A$0.23 B	🇺🇸 USA
Gilead Sciences GILD	A$26.28 M	A$0.23 B	🇺🇸 USA
Celldex Therapeutics CLDX	A$2.55 M	A$6.31 M	🇺🇸 USA
GlaxoSmithKline GSK	A$25.51 M	A$53.86 M	🇬🇧 UK
Emergent BioSolutions EBS	A$1.1 M	A$5.09 M	🇺🇸 USA
Cel-Sci CVM	A$0.97 M	A$5.46 M	🇺🇸 USA